DJIA 17,356.87 0.00 0.00%
NASDAQ 4,644.31 0.00 0.00%
S&P 500 2,012.89 0.00 0.00%
market minute promo

Pfizer (NYSE: PFE)

31.12 0.00 (0.00%)

REAL-TIME: Last trade at

Extended Hours: $31.34 $0.22 (0.71%)
Quote as of (NYSE)



company name or ticker

Recent Quotes

PFE $31.12 0.00%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $30.70
Previous Close $31.12
Daily Range $30.58 - $31.35
52-Week Range $27.51 - $33.12
Market Cap $196.1B
P/E Ratio 18.93
Dividend (Yield) $1.12 (3.4%)
Ex-Dividend Date
Dividend Pay Date
11/05/14
12/02/14
Volume 24,657,025
Average Daily Volume 23,390,189
Current FY EPS $2.26

Sector

Healthcare

Industry

Drugs

Pfizer (PFE) Description

A research-based pharmaceutical company, Pfizer discovers, develops, manufactures, and markets prescription medicines such as Lipitor, Celebrex, and Viagra. Website: http://www.pfizer.com/

News & Commentary

Why The Smart Money is Betting Billions On PetSmart

In one of the biggest leveraged buyouts of the year, the pet supplier strains at the leash of valuation

Pfizer Is A Great Income Stock On A Pullback

Jacobs Drives Organic Growth on Award-Winning Contract - Analyst Blog

OncoGenex's Pancreatic Cancer Study Fully Enrolled - Analyst Blog

Pfizer’s Acquisition Strategy: Will Pfizer Still Go For A Big Acquisition? (Part 1 of 2)

Pfizer's Acquisition Strategy: Will Pfizer Still Go For A Big Acquisition?

Better Big Pharma Spinoff: Zoetis Inc. or AbbVie Inc.?

Both AbbVie and Zoetis offer something for healthcare investors.

Health Care Sector Update for 12/17/2014: CARA, PFE, ORPN

Pfizer, Inc. Invests in Growth... Literally

Pfizer, Inc. pays $275 million upfront for commercialization rights to Opko Health Inc.'s promising human growth hormone drug.

Baxter to Vend Vero Cell Vaccine Platform to Nanotherapeutics - Analyst Blog

See More PFE News...

PFE's Top Competitors

PFE $31.12 (0.00%)
Current stock: PFE
JNJ $104.07 (0.00%)
Current stock: JNJ
ROG $70.65 (0.00%)
Current stock: ROG
GSK $42.04 (0.00%)
Current stock: GSK